DGI-043 Increased Cost of Erythropoiesis-Stimulating Agents in Some Special Situations

European Journal of Hospital Pharmacy: Science and Practice - Belgium
doi 10.1136/ejhpharm-2013-000276.309
Full Text
Abstract

Available in full text

Categories
Pharmacy
Date
Authors
Publisher

BMJ

Related search

PCN34 Cost Analysis of Anemia Treatment With Erythropoiesis-Stimulating Agents (ESAs) in Cancer Patients Receiving Chemotherapy in Italy

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2011English

Factors Stimulating Erythropoiesis in Frogs

Blood
BiochemistryImmunologyCell BiologyHematology
1963English

Intravenous Iron and Erythropoiesis-Stimulating Agents in Haemodialysis: A Systematic Review and Meta-Analysis

Nephrology
MedicineNephrology
2017English

Differential Modulation of Angiogenesis by Erythropoiesis-Stimulating Agents in a Mouse Model of Ischaemic Retinopathy

PLoS ONE
Multidisciplinary
2010English

Erythropoiesis-Stimulating Agents Increase the Risk of Acute Stroke in Patients With Chronic Kidney Disease

Kidney International
Nephrology
2011English

Assessing the Quality of Prescribing and Monitoring Erythropoiesis-Stimulating Agents in the Nursing Home Setting

Journal of the American Medical Directors Association
MedicineHealth PolicyGerontologyGeriatricsNursing
2009English

Association Between High-Dose Erythropoiesis-Stimulating Agents, Inflammatory Biomarkers, and Soluble Erythropoietin Receptors

BMC Nephrology
Nephrology
2011English

Effect of Long-Acting Erythropoiesis-Stimulating Agents on Hemoglobin Levels at the Initiation of Dialysis

Renal Replacement Therapy
2016English

Treatment Options for Anemia, Taking Risks Into Consideration: Erythropoiesis-Stimulating Agents Versus Transfusions

Oncologist
Cancer ResearchMedicineOncology
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy